Atomo Diagnostics Management
Management criteria checks 3/4
Atomo Diagnostics' CEO is John Kelly, appointed in Jan 2010, has a tenure of 14.25 years. total yearly compensation is A$542.02K, comprised of 76.9% salary and 23.1% bonuses, including company stock and options. directly owns 1.15% of the company’s shares, worth A$221.11K. The average tenure of the management team and the board of directors is 2 years and 4.2 years respectively.
Key information
John Kelly
Chief executive officer
AU$542.0k
Total compensation
CEO salary percentage | 76.9% |
CEO tenure | 14.3yrs |
CEO ownership | 1.2% |
Management average tenure | 2yrs |
Board average tenure | 4.2yrs |
Recent management updates
Recent updates
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Jul 05We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Oct 10Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?
Jun 10We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn
Dec 06Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 01We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow
Jul 19Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)
Feb 26Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business
Jan 22Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like
Dec 18When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?
Jul 16CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -AU$7m |
Sep 30 2023 | n/a | n/a | -AU$9m |
Jun 30 2023 | AU$542k | AU$417k | -AU$10m |
Mar 31 2023 | n/a | n/a | -AU$9m |
Dec 31 2022 | n/a | n/a | -AU$9m |
Sep 30 2022 | n/a | n/a | -AU$7m |
Jun 30 2022 | AU$533k | AU$368k | -AU$6m |
Mar 31 2022 | n/a | n/a | -AU$6m |
Dec 31 2021 | n/a | n/a | -AU$6m |
Sep 30 2021 | n/a | n/a | -AU$6m |
Jun 30 2021 | AU$467k | AU$372k | -AU$6m |
Mar 31 2021 | n/a | n/a | -AU$8m |
Dec 31 2020 | n/a | n/a | -AU$10m |
Sep 30 2020 | n/a | n/a | -AU$9m |
Jun 30 2020 | AU$611k | AU$298k | -AU$9m |
Mar 31 2020 | n/a | n/a | -AU$7m |
Dec 31 2019 | n/a | n/a | -AU$5m |
Sep 30 2019 | n/a | n/a | -AU$5m |
Jun 30 2019 | AU$319k | AU$248k | -AU$5m |
Compensation vs Market: John's total compensation ($USD352.26K) is about average for companies of similar size in the Australian market ($USD290.69K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Kelly
14.3yrs
Tenure
AU$542,017
Compensation
Mr. John Michael Kelly founded Atomo Diagnostics Ltd. in 2010 and serves as its Chief Executive Officer & Managing Director. Mr. Kelly has significant med-tech experience, having held senior operational an...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 14.3yrs | AU$542.02k | 1.15% A$ 221.1k | |
Chief Operating Officer | 2yrs | AU$324.29k | 0.027% A$ 5.1k | |
Head of Business Development & Partnerships of the Americas | 2yrs | no data | no data | |
Head of Business Development & Partnerships of Europe | 2yrs | no data | no data | |
Company Secretary | 1.1yrs | no data | no data |
2.0yrs
Average Tenure
Experienced Management: AT1's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 14yrs | AU$542.02k | 1.15% A$ 221.1k | |
Independent Non-Executive Director | 2.6yrs | AU$88.33k | no data | |
Independent Non-Executive Director | 1.4yrs | AU$31.25k | no data | |
Independent Non-Executive Director | 4.2yrs | AU$70.00k | 0.016% A$ 3.0k | |
Independent Non-Executive Chairman | 12.3yrs | AU$130.00k | 0.51% A$ 97.8k | |
Member of Advisory Board | no data | no data | no data |
4.2yrs
Average Tenure
Experienced Board: AT1's board of directors are considered experienced (4.2 years average tenure).